Edition:
United States

Derma Sciences Inc (DSCI.OQ)

DSCI.OQ on NASDAQ Stock Exchange Capital Market

4.93USD
23 Sep 2016
Change (% chg)

-- (--)
Prev Close
$4.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,910
52-wk High
$6.38
52-wk Low
$2.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.04 December 26 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 1 23.90 23.90 23.90 23.24
Quarter Ending Dec-16 1 26.10 26.10 26.10 26.84
Year Ending Dec-16 1 92.40 92.40 92.40 96.74
Year Ending Dec-17 1 109.50 109.50 109.50 106.79
Earnings (per share)
Quarter Ending Sep-16 1 -0.04 -0.04 -0.04 -0.29
Quarter Ending Dec-16 1 0.00 0.00 0.00 -0.24
Year Ending Dec-16 1 -0.04 -0.04 -0.04 -1.39
Year Ending Dec-17 1 0.10 0.10 0.10 -0.85

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 22.40 22.21 0.19 0.86
Quarter Ending Mar-16 20.60 20.24 0.36 1.73
Quarter Ending Dec-15 20.21 20.25 0.04 0.19
Quarter Ending Sep-15 22.31 22.17 0.14 0.65
Quarter Ending Jun-15 21.66 22.56 0.90 4.15
Earnings (per share)
Quarter Ending Jun-16 -0.08 -0.07 0.01 -12.50
Quarter Ending Mar-16 -0.13 -0.07 0.06 -46.15
Quarter Ending Dec-15 -0.39 -0.26 0.13 -33.33
Quarter Ending Sep-15 -0.43 -0.35 0.08 -17.65
Quarter Ending Jun-15 -0.42 -0.36 0.06 -15.09

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 23.90 23.90 23.90 22.90 23.24
Quarter Ending Dec-16 26.10 26.10 26.10 23.50 26.84
Year Ending Dec-16 92.40 92.40 92.40 89.10 96.74
Year Ending Dec-17 109.50 109.50 109.50 95.00 106.79
Earnings (per share)
Quarter Ending Sep-16 -0.04 -0.04 -0.04 -0.04 -0.29
Quarter Ending Dec-16 0.00 0.00 0.00 -0.02 -0.24
Year Ending Dec-16 -0.04 -0.04 -0.04 -0.20 -1.39
Year Ending Dec-17 0.10 0.10 0.06 -0.10 -0.85

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 1 0

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.